Iceland· IS-EU/1/14/970/005
RIXUBIS
A coagulation factor ix product containing nonacogum alfa inn, registered in Iceland by Baxalta Innovations GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Coagulation factor ix is registered in 12 of 19 countries.
Countries holding a registration under ATC B02BD04 (coagulation factor ix), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Coagulation factor ix · ATC B02BD04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Nonacogum alfa INN
- Manufacturer
- Baxalta Innovations GmbH
- Country
- Iceland (IS)
- ATC code
- B02BD04
- ATC class
- Coagulation factor IX
- Defined daily dose
- 600 E, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for coagulation factor ix.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor ix · interactions on record
3 records
- 2 severe
- 1 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- PegvaliaseA16AB19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Coagulation factor ix in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBeneFIX 1000 IUPfizer Europe MA
- SwedenBeneFIX 1000 IE Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- CzechiaBENEFIXPfizer Europe MA EEIG, Bruxelles
- FinlandBenefixPfizer Europe MA EEIG
- IrelandBeneFIX 1000 IU powder and solvent for solution for injectionPfizer Europe MA EEIG
- PolandBeneFixPfizer Europe MA EEIG
- NetherlandsBeneFIX 1000 IE, poeder voor injectievloeistofPfizer Europe MA EEIG
- United KingdomBeneFIX 1,000unit powder and solvent for solution for infusion vialsPfizer Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Benefix, Rixubis
- Norway · Benefix, Rixubis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab54d4c5-559e-4996-af73-e851f92800a3 GET /v1/drugs/ab54d4c5-559e-4996-af73-e851f92800a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyfsstofn og leysir, lausn",
"source": "lyfjastofnun",
"atc_raw": "B02BD04",
"marketed": false,
"strength": "3000 a.e.",
"ma_number": "EU/1/14/970/005",
"substance": "Nonacogum alfa INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í blóðsjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "41992"
}See everything about coagulation factor ix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.